- Home
- SVMH vs EDSA Comparison
SVMH vs EDSA Comparison
Compare SVMH & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVMH
- EDSA
- Stock Information
- Founded
- SVMH 2018
- EDSA 2015
- Country
- SVMH Cayman Islands
- EDSA Canada
- Employees
- SVMH N/A
- EDSA N/A
- Industry
- SVMH
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- SVMH
- EDSA Health Care
- Exchange
- SVMH Nasdaq
- EDSA Nasdaq
- Market Cap
- SVMH 7.3M
- EDSA 6.2M
- IPO Year
- SVMH N/A
- EDSA N/A
- Fundamental
- Price
- SVMH $0.86
- EDSA $1.70
- Analyst Decision
- SVMH
- EDSA Strong Buy
- Analyst Count
- SVMH 0
- EDSA 1
- Target Price
- SVMH N/A
- EDSA $21.00
- AVG Volume (30 Days)
- SVMH 7.8M
- EDSA 17.7K
- Earning Date
- SVMH 02-15-2025
- EDSA 02-07-2025
- Dividend Yield
- SVMH N/A
- EDSA N/A
- EPS Growth
- SVMH N/A
- EDSA N/A
- EPS
- SVMH N/A
- EDSA N/A
- Revenue
- SVMH $42,538.00
- EDSA N/A
- Revenue This Year
- SVMH N/A
- EDSA N/A
- Revenue Next Year
- SVMH N/A
- EDSA N/A
- P/E Ratio
- SVMH N/A
- EDSA N/A
- Revenue Growth
- SVMH N/A
- EDSA N/A
- 52 Week Low
- SVMH $0.02
- EDSA $1.55
- 52 Week High
- SVMH $1.24
- EDSA $5.99
- Technical
- Relative Strength Index (RSI)
- SVMH 78.57
- EDSA 40.80
- Support Level
- SVMH $0.65
- EDSA $1.56
- Resistance Level
- SVMH $1.23
- EDSA $1.97
- Average True Range (ATR)
- SVMH 0.09
- EDSA 0.15
- MACD
- SVMH 0.09
- EDSA 0.02
- Stochastic Oscillator
- SVMH 68.21
- EDSA 31.84
About SVMH SRIVARU Holding Limited
SRIVARU Holding Ltd focuses to revolutionize two-wheeled vehicles (TWV) by developing products powered by renewable energy, which are assured for safety, performance, and comfort, thereby providing safe riding experience to its customers. It operates in one reportable segment which is vehicle manufacturing. SVH's first product line, the Prana, is a E2W vehicle that is redefining the category. SVH has commenced engineering and design work for the Prana-Elite that is expected to leverage the same platform as the Prana-Grand, while upgrading its range.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.